Cargando…
N(6)‐methyladenosine‐modified lncRNA ARHGAP5‐AS1 stabilises CSDE1 and coordinates oncogenic RNA regulons in hepatocellular carcinoma
BACKGROUND: Hepatocellular carcinoma (HCC) ranks fourth among the malignancies leading to cancer‐related deaths all around the world. It is increasingly evident that long non‐coding RNAs (lncRNAs) are a key mode of hepatocarcinogenesis. As the most prevalent mRNA modification form, N (6)‐methyladeno...
Autores principales: | Liu, Jiandong, Zhang, Nasha, Zeng, Jiajia, Wang, Teng, Shen, Yue, Ma, Chi, Yang, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647857/ https://www.ncbi.nlm.nih.gov/pubmed/36354136 http://dx.doi.org/10.1002/ctm2.1107 |
Ejemplares similares
-
Impaired autophagic degradation of lncRNA ARHGAP5-AS1 promotes chemoresistance in gastric cancer
por: Zhu, Liyuan, et al.
Publicado: (2019) -
Strap associates with Csde1 and affects expression of select Csde1-bound transcripts
por: Moore, Kat S., et al.
Publicado: (2018) -
FEZF1-AS1 functions as an oncogenic lncRNA in retinoblastoma
por: Quan, Lian-Jiao, et al.
Publicado: (2019) -
New insights on the interplays between m(6)A modifications and microRNA or lncRNA in gastrointestinal cancers
por: Su, Tao, et al.
Publicado: (2023) -
lncRNA PVT1: a novel oncogene in multiple cancers
por: Li, Ruiming, et al.
Publicado: (2022)